NTRA
Natera Inc
NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.75
-2.71% today
Updated 2026-04-29
Market cap
$27.81B
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-1.52
Dividend yield
—
52W range
$132 – $256
Volume
1.3M
Natera Inc (NTRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.90M | $-24.13M | $10.49M | $-37.83M | $-74.05M | $-97.83M | $-70.58M | $-63.44M | $-182.51M | $-335.24M | $-431.50M | $-246.96M | $135.66M | $215.30M |
| Capital expenditures | $4.59M | $8.24M | $9.96M | $7.85M | $23.14M | $9.87M | $3.88M | $4.97M | $19.60M | $41.03M | $47.70M | $39.20M | $66.42M | $106.19M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $605000.00 | $1.66M | $5.16M | $7.33M | $10.60M | $11.40M | $14.20M | $28.62M | $50.17M | $115.22M | $152.38M | $191.81M | $274.43M | $354.40M |
| Free cash flow | $-19.49M | $-32.38M | $533000.00 | $-45.68M | $-97.19M | $-107.69M | $-74.46M | $-68.41M | $-202.12M | $-376.27M | $-479.20M | $-286.15M | $69.24M | $109.11M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $2.59M | $0.00 | — | — | $7.11M | — | $30.00M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-58.23M | $-13.69M | $-2.64M | $37.98M | $10.98M | $-13.13M | $35.76M | $381.48M | — | — | — |